VELIPARIB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 24 adverse event reports in the FDA FAERS database where VELIPARIB was used for Breast cancer.
Most Reported Side Effects for VELIPARIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutrophil count decreased | 124 | 31.7% | 7 | 67 |
| Anaemia | 118 | 30.2% | 6 | 63 |
| White blood cell count decreased | 94 | 24.0% | 6 | 53 |
| Febrile neutropenia | 76 | 19.4% | 0 | 69 |
| Platelet count decreased | 70 | 17.9% | 6 | 37 |
| Hypertension | 57 | 14.6% | 3 | 33 |
| Nausea | 46 | 11.8% | 2 | 38 |
| Hyponatraemia | 38 | 9.7% | 4 | 22 |
| Vomiting | 36 | 9.2% | 1 | 30 |
| Hypokalaemia | 31 | 7.9% | 3 | 25 |
| Dehydration | 29 | 7.4% | 4 | 25 |
| Abdominal pain | 24 | 6.1% | 1 | 23 |
| Diarrhoea | 23 | 5.9% | 1 | 20 |
| Fatigue | 23 | 5.9% | 0 | 16 |
| Embolism | 19 | 4.9% | 1 | 13 |
Other Indications for VELIPARIB
Ovarian epithelial cancer (97)
Triple negative breast cancer (67)
Colorectal cancer (39)
Fallopian tube cancer (21)
Ovarian cancer (16)
Colorectal cancer metastatic (14)
Malignant peritoneal neoplasm (11)
Neoplasm (9)
Breast cancer metastatic (8)
Cervix carcinoma recurrent (8)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)